NutriStack
Aripiprazole and Cannabis (THC-Dominant), a conflict.
THC-dominant cannabis can work against the treatment goals of aripiprazole in psychosis or bipolar disorder. Continued cannabis use after a psychotic episode is linked with higher relapse rates, poorer adherence, and more antipsychotic treatment failure. Risk is highest with daily use, high-potency THC products, prior cannabis-induced psychosis, or recent hospitalization.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Aripiprazole and Cannabis (THC-Dominant)
- Pair type
- Conflict
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- −10 to your Stack Score (per scored conflict row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Conflict · Strong evidence
Conflict
What is happening. THC-dominant cannabis can work against the treatment goals of aripiprazole in psychosis or bipolar disorder. Continued cannabis use after a psychotic episode is linked with higher relapse rates, poorer adherence, and more antipsychotic treatment failure. Risk is highest with daily use, high-potency THC products, prior cannabis-induced psychosis, or recent hospitalization.
Mechanism. THC is a psychoactive cannabinoid that can provoke or worsen psychotic symptoms through CB1 receptor effects on dopaminergic and glutamatergic signaling. Cannabis use also increases the likelihood of missed antipsychotic doses, creating a pharmacodynamic and behavioral conflict with relapse prevention.
Recommendation. Avoid THC-dominant cannabis while taking aripiprazole for psychosis or mood stabilization. If you are already using cannabis, tell your prescriber because relapse risk and medication adherence need closer monitoring. Separating the timing of cannabis and aripiprazole does not remove this risk.
Sources (2)
- Schoeler T, Monk A, Sami MB, Klamerus E, Foglia E, Brown R, et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(3):215-225. PMID 26777297
- Reid S, Bhattacharyya S. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review. Psychiatry Res. 2019;280:112523. PMID 31450032
Stack Score
How this pair moves the number.
Effect on the composite score
If both Aripiprazole and Cannabis (THC-Dominant) are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.